Erratum: Genome-wide analyses of radioresistance-associated miRNA expression profile in nasopharyngeal carcinoma using next generation deep sequencing (PLoS ONE (2014) 8:12 (e84486) DOI: 10.1371/journal.pone.0084486));Genome-wide analyses of radioresistance-associated miRNA expression profile in nasopharyngeal carcinoma using next generation deep sequencing

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Li, Guo ^a,b   Qiu, Yuanzheng ^a,b   Su, Zhongwu ^a,b   Ren, Shuling ^a,b   Liu, Chao ^a,b   Tian, Yongquan ^a,b   Liu, Yong ^a,b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Otolaryngology Major Disease Research Key Laboratory of Hunan Province   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 1323; MICRORNA 324; MICRORNA 34C; MICRORNA 371A; MICRORNA 4501; MICRORNA 93; UNCLASSIFIED DRUG;

ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE INTERACTION; GENE TARGETING; GENETIC CORRELATION; GENETIC DIFFERENCE; GENOME ANALYSIS; HIGH THROUGHPUT SEQUENCING; NASOPHARYNX CARCINOMA; RADIOSENSITIVITY; RNA SEQUENCE; SIGNAL TRANSDUCTION; UPREGULATION;

BASE SEQUENCE; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MICRORNAS; NASOPHARYNGEAL NEOPLASMS; RADIATION TOLERANCE; SEQUENCE ANALYSIS, RNA;

EID: 84893174653     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110099     Document Type: Erratum

References (57)

1. Fåhraeus R, Fu HL, Ernberg I, Finke J, Rowe M et al. (1988) Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Int J Cancer 42: 329-338. doi:10.1002/ijc.2910420305. PubMed: 2843473.
2. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63: 11-30. doi:10.3322/caac.21166. PubMed: 23335087.
3. Chatani M, Teshima T, Inoue T, Azuma I, Yoshimura H et al. (1986) Radiation therapy for nasopharyngeal carcinoma. Retrospective review of 105 patients based on a survey of Kansai Cancer Therapist Group. Cancer 57: 2267-2271. doi:10.1002/1097-0142(19860615)57:12. PubMed: 3084058.
4. Feng XP, Yi H, Li MY, Li XH, Yi B et al. (2010) Identification of biomarkers for predicting nasopharyngeal carcinoma response to radiotherapy by proteomics. Cancer Res 70: 3450-3462. doi:10.1158/1538-7445.AM10-3450. PubMed: 20406978.
5. Guo Y, Zhu XD, Qu S, Li L, Su F et al. (2012) Identification of genes involved in radioresistance of nasopharyngeal carcinoma by integrating gene ontology and protein-protein interaction networks. Int J Oncol 40: 85-92. PubMed: 21874234.
6. Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233. doi:10.1016/j.cell.2009.01.002. PubMed: 19167326.
7. Ng EK, Wong CL, Ma ES, Kwong A (2009) MicroRNAs as New Players for Diagnosis, Prognosis, and Therapeutic Targets in Breast Cancer. J Oncol 2009: 305420.
8. Sevignani C, Calin GA, Nnadi SC, Shimizu M, Davuluri RV et al. (2007) MicroRNA genes are frequently located near mouse cancer susceptibility loci. Proc Natl Acad Sci U S A 104: 8017-8022. doi:10.1073/pnas.0702177104. PubMed: 17470785.
9. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E et al. (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 101: 2999-3004. doi:10.1073/pnas.0307323101. PubMed: 14973191.
10. Frankel LB, Lund AH (2012) MicroRNA regulation of autophagy. Carcinogenesis 33: 2018-2025. doi:10.1093/carcin/bgs266. PubMed: 22902544.
11. Zhang H, Pu J, Qi T, Qi M, Yang C et al. (2012) MicroRNA-145 inhibits the growth, invasion, metastasis and angiogenesis of neuroblastoma cells through targeting hypoxia-inducible factor 2 alpha. Oncogene. doi:10.1038/onc.2012.574. PubMed: 23222716.
12. Si ML, Zhu S, Wu H, Lu Z, Wu F et al. (2007) miR-21-mediated tumor growth. Oncogene 26: 2799-2803. doi:10.1038/sj.onc.1210083. PubMed: 17072344.
13. Guo L, Yong L, Zhongwu S, Shuling R, Gangcai Z et al. (2013) MicroRNA-324-3p regulates nasopharyngeal carcinoma radioresistance by directly targeting WNT2B. Eur J Cancer 49: 2596-2607. doi:10.1016/j.ejca.2013.03.001.
14. Liang Z, Ahn J, Guo D, Votaw JR, Shim H (2013) MicroRNA-302 Replacement Therapy Sensitizes Breast Cancer Cells to Ionizing Radiation. Pharm Res 30: 1008-1016. doi:10.1007/s11095-012-0936-9. PubMed: 23184229.
15. Lynam-Lennon N, Reynolds JV, Marignol L, Sheils OM, Pidgeon GP et al. (2012) MicroRNA-31 modulates tumour sensitivity to radiation in oesophageal adenocarcinoma. J Mol Med (Berl) 90: 1449-1458. doi:10.1007/s00109-012-0924-x. PubMed: 22706599.
16. Qu C, Liang Z, Huang J, Zhao R, Su C et al. (2012) MiR-205 determines the radioresistance of human nasopharyngeal carcinoma by directly targeting PTEN. Cell Cycle 11: 785-796. doi:10.4161/cc.11.4.19228. PubMed: 22374676.
17. Oh JS, Kim JJ, Byun JY, Kim IA (2010) Lin28-let7 modulates radiosensitivity of human cancer cells with activation of K-Ras. Int J Radiat Oncol Biol Phys 76: 5-8. doi:10.1016/j.ijrobp.2009.08.028. PubMed: 20005451.
18. Li T, Chen JX, Fu XP, Yang S, Zhang Z et al. (2011) microRNA expression profiling of nasopharyngeal carcinoma. Oncol Rep 25: 1353-1363. PubMed: 21373758.
19. Mao W, Li Z, Xia X, Li Y, Yu J (2012) A combined approach of high-throughput sequencing and degradome analysis reveals tissue specific expression of microRNAs and their targets in cucumber. PLOS ONE 7: e33040. doi:10.1371/journal.pone.0033040. PubMed: 22479356.
20. Li R, Li Y, Kristiansen K, Wang J (2008) SOAP: short oligonucleotide alignment program. Bioinformatics 24: 713-714. doi:10.1093/bioinformatics/ btn025. PubMed: 18227114.
21. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B (2008) Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 5: 621-628. doi:10.1038/nmeth.1226. PubMed: 18516045.
22. Rehmsmeier M, Steffen P, Hochsmann M, Giegerich R (2004) Fast and effective prediction of microRNA/target duplexes. RNA 10: 1507-1517. doi:10.1261/rna.5248604. PubMed: 15383676.
23. Allen E, Xie Z, Gustafson AM, Carrington JC (2005) microRNA-directed phasing during trans-acting siRNA biogenesis in plants. Cell 121: 207-221. doi:10.1016/j.cell.2005.04.004. PubMed: 15851028.
24. Schwab R, Palatnik JF, Riester M, Schommer C, Schmid M et al. (2005) Specific effects of microRNAs on the plant transcriptome. Dev Cell 8: 517-527. doi:10.1016/j.devcel.2005.01.018. PubMed: 15809034.
25. Aoki-Kinoshita KF, Kanehisa M (2007) Gene annotation and pathway mapping in KEGG. Methods Mol Biol 396: 71-91. doi:10.1007/978-1-59745-515-2-6. PubMed: 18025687.
26. Berezikov E, Cuppen E, Plasterk RH (2006) Approaches to microRNA discovery. Nat Genet 38 Suppl: S2-S7. doi:10.1038/ng1794. PubMed: 16736019.
27. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ (2006) miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34: D140-D144. doi:10.1093/nar/gkj430. PubMed: 16381832.
28. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB (2003) Prediction of mammalian microRNA targets. Cell 115: 787-798. doi:10.1016/S0092-8674(03)01018-3. PubMed: 14697198.
29. Krek A, Grün D, Poy MN, Wolf R, Rosenberg L et al. (2005) Combinatorial microRNA target predictions. Nat Genet 37: 495-500. doi:10.1038/ng1536. PubMed: 15806104.
30. Cheng JJ, Hu Z, Xia YF, Chen ZP (2006) Radioresistant subline of human glioma cell line MGR2R induced by repeated high dose X-ray irradiation. Ai Zheng 25: 45-50. PubMed: 16405748.
31. Lee HC, Kim DW, Jung KY, Park IC, Park MJ et al. (2004) Increased expression of antioxidant enzymes in radioresistant variant from U251 human glioblastoma cell line. Int J Mol Med 13: 883-887. PubMed: 15138630.
32. Virsik-Köpp P, Hofman-Hüther H, Rave-Fränk M, Schmidberger H (2005) The effect of wortmannin on radiation-induced chromosome aberration formation in the radioresistant tumor cell line WiDr. Radiat Res 164: 148-156. doi:10.1667/RR3396.1. PubMed: 16138421.
33. Henness S, Davey MW, Harvie RM, Davey RA (2002) Fractionated irradiation of H69 small-cell lung cancer cells causes stable radiation and drug resistance with increased MRP1, MRP2, and topoisomerase IIalpha expression. Int J Radiat Oncol Biol Phys 54: 895-902. doi:10.1016/S0360-3016(02)03037-7. PubMed: 12377343.
34. Jiang L, Huang Q, Zhang S, Zhang Q, Chang J et al. (2010) Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells. BMC Cancer 10: 318. doi:10.1186/1471-2407-10-318. PubMed: 20569443.
35. Hashiguchi Y, Nishida N, Mimori K, Sudo T, Tanaka F et al. (2012) Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance. Int J Oncol 40: 1477-1482. PubMed: 22322911.
36. Luo Z, Zhang L, Li Z, Jiang C, Dai Y et al. (2011) miR-149 promotes epithelial-mesenchymal transition and invasion in nasopharyngeal carcinoma cells. Zhong NAN da Xue Xue Bao Yi Xue Ban 36: 604-609. PubMed: 21873783.
37. Wang F, Ma YL, Zhang P, Shen TY, Shi CZ et al. (2013) SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer. J Pathol 229: 12-24. doi:10.1002/path.4078. PubMed: 22821729.
38. Lin RJ, Lin YC, Yu AL (2010) miR-149* induces apoptosis by inhibiting Akt1 and E2F1 in human cancer cells. Mol Carcinog 49: 719-727. PubMed: 20623644.
39. Li Y, Xu X, Liang Y, Liu S, Xiao H, et al. (2010) miR-375 enhances palmitate-induced lipoapoptosis in insulin-secreting NIT-1 cells by repressing myotrophin (V1) protein expression. Int J Clin Exp Pathol 3: 254-264.
40. Wang F, Li Y, Zhou J, Xu J, Peng C et al. (2011) miR-375 is downregulated in squamous cervical cancer and inhibits cell migration and invasion via targeting transcription factor SP1. Am J Pathol 179: 2580-2588. doi:10.1016/j.ajpath.2011.07.037. PubMed: 21945323.
41. Ho CM, Lee PH, Hu RH (2011) Clinical correlation of miR-375 and alpha-fetoprotein in hepatocellular carcinoma: comparison in mice and humans. Hepatology 54: 1105-1106. doi:10.1002/hep.24521. PubMed: 21735465.
42. Zhai Q, Zhou L, Zhao C, Wan J, Yu Z et al. (2012) Identification of miR-508-3p and miR-509-3p that are associated with cell invasion and migration and involved in the apoptosis of renal cell carcinoma. Biochem Biophys Res Commun 419: 621-626. doi:10.1016/j.bbrc.2012.02.060. PubMed: 22369946.
43. Cai KM, Bao XL, Kong XH, Jinag W, Mao MR et al. (2010) Hsa-miR-34c suppresses growth and invasion of human laryngeal carcinoma cells via targeting c-Met. Int J Mol Med 25: 565-571. PubMed: 20198305.
44. Catuogno S, Cerchia L, Romano G, Pognonec P, Condorelli G et al. (2013) miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis. Oncogene 32: 341-351. doi:10.1038/onc.2012.51. PubMed: 22370637.
45. Schmitz KJ, Helwig J, Bertram S, Sheu SY, Suttorp AC et al. (2011) Differential expression of microRNA-675, microRNA-139-3p and microRNA-335 in benign and malignant adrenocortical tumours. J Clin Pathol 64: 529-535. doi:10.1136/jcp.2010.085621. PubMed: 21471143.
46. Wong CC, Wong CM, Tung EK, Au SL, Lee JM et al. (2011) The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2. Gastroenterology 140: 322-331. doi:10.1053/j.gastro.2010.10.006. PubMed: 20951699.
47. Croce CM (2009) Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10: 704-714. doi:10.1038/nrg2634. PubMed: 19763153.
48. Zhang M, Kleber S, Röhrich M, Timke C, Han N et al. (2011) Blockade of TGF-beta signaling by the TGFbetaR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma. Cancer Res 71: 7155-7167. doi:10.1158/0008-5472.CAN-11-1212. PubMed: 22006998.
49. Woodward WA, Chen MS, Behbod F, Alfaro MP, Buchholz TA et al. (2007) WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc Natl Acad Sci U S A 104: 618-623. doi:10.1073/pnas.0606599104. PubMed: 17202265.
50. Roses RE, Xu M, Koski GK, Czerniecki BJ (2008) Radiation therapy and Toll-like receptor signaling: implications for the treatment of cancer. Oncogene, 27: 200-207. doi:10.1038/sj.onc.1210909. PubMed: 18176601.
51. Singh D, Joshi DD, Hameed M, Qian J, Gascón P et al. (2000) Increased expression of preprotachykinin-I and neurokinin receptors in human breast cancer cells: implications for bone marrow metastasis. Proc Natl Acad Sci U S A 97: 388-393. doi:10.1073/pnas.97.1.388. PubMed: 10618428.
52. Evan GI, Vousden KH (2001) Proliferation, cell cycle and apoptosis in cancer. Nature 411: 342-348. doi:10.1038/35077213. PubMed: 11357141.
53. Ma X, Yang L, Xiao L, Tang M, Liu L et al. (2011) Down-regulation of EBV-LMP1 radio-sensitizes nasal pharyngeal carcinoma cells via NF-κB regulated ATM expression. PLOS ONE 6: e24647. doi:10.1371/journal.pone.0024647. PubMed: 22096476.
54. Navarro A, Gaya A, Martinez A, Urbano-Ispizua A, Pons A et al. (2008) MicroRNA expression profiling in classic Hodgkin lymphoma. Blood 111: 2825-2832. doi:10.1182/blood-2007-06-096784. PubMed: 18089852.
55. Von Rahden BH, Stein HJ, Feith M, Pühringer F, Theisen J et al. (2006) Overexpression of TGF-β1 in esophageal (Barrett's) adenocarcinoma is associated with advanced stage of disease and poor prognosis. Mol Carcinog 45: 786-794. doi:10.1002/mc.20259. PubMed: 16921482.
56. Kesanakurti D, Chetty C, Maddirela DR, Gujrati M, Rao JS (2013) Essential role of cooperative NF-κB and Stat3 recruitment to ICAM-1 intronic consensus elements in the regulation of radiation-induced invasion and migration in glioma. Oncogene 32: 5144-5155. doi:10.1038/onc.2012.546. PubMed: 23178493.
57. Guo L, Yong L, Zhongwu S, Shuling R, Chao L, et al. (2013) Irradiation induced epithelial-mesenchymal transition in nasopharyngeal carcinoma in vitro. Zhong hua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 48: 662-667